Eurocine Vaccines has selected Biovian as contract developer for the chlamydia vaccine candidate
Eurocine Vaccines AB has selected Biovian Oy, Turku, Finland, as the contract developer for the Company’s vaccine candidate against chlamydia. Biovian, which is an internationally recognized contract developer and manufacturer with its own GMP facility, will develop an industrial manufacturing method as well as manufacture study products for Eurocine Vaccines´ future studies, such as toxicological and clinical studies.
“The selection of Biovian means that we can conduct our activities with continuity, since they also have their own GMP facility for the manufacture of products for clinical studies. -CEO Hans Arwidsson
